Peptide mimetics of apolipoproteins improve HDL function
- 31 May 2007
- journal article
- review article
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 1 (2) , 142-147
- https://doi.org/10.1016/j.jacl.2007.03.002
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Oral amphipathic peptides as therapeutic agentsExpert Opinion on Investigational Drugs, 2005
- Effects of D-4F on Vasodilation and Vessel Wall Thickness in Hypercholesterolemic LDL Receptor–Null and LDL Receptor/Apolipoprotein A-I Double-Knockout Mice on Western DietCirculation Research, 2005
- Oral Small Peptides Render HDL Antiinflammatory in Mice and Monkeys and Reduce Atherosclerosis in ApoE Null MiceCirculation Research, 2005
- An Oral ApoJ Peptide Renders HDL Antiinflammatory in Mice and Monkeys and Dramatically Reduces Atherosclerosis in Apolipoprotein E–Null MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Inhibition of Lipopolysaccharide-Induced Inflammatory Responses by an Apolipoprotein AI Mimetic PeptideCirculation Research, 2005
- D-4F and Statins Synergize to Render HDL Antiinflammatory in Mice and Monkeys and Cause Lesion Regression in Old Apolipoprotein E–Null MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Apolipoprotein E Mimetic Peptide Dramatically Lowers Plasma Cholesterol and Restores Endothelial Function in Watanabe Heritable Hyperlipidemic RabbitsCirculation, 2005
- An Apolipoprotein AI Mimetic Peptide: Membrane Interactions and the Role of Cholesterol,Biochemistry, 2004
- New to Journal of Lipid ResearchJournal of Lipid Research, 2002
- Efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptidesBiochemistry, 1995